US HB1046 | 2019-2020 | 116th Congress

Status

Spectrum: Partisan Bill (Democrat 128-0)
Status: Introduced on February 7 2019 - 25% progression, died in chamber
Action: 2019-09-25 - Subcommittee Hearings Held.
Text: Latest bill text (Introduced) [PDF]

Summary

Requires the Centers for Medicare & Medicaid Services (CMS) to negotiate with pharmaceutical companies regarding prices for drugs covered under the Medicare prescription drug benefit. (Current law prohibits the CMS from doing so.) The CMS must take certain factors into account during negotiations, including the clinical- and cost-effectiveness of the drug, the financial burden on patients, and unmet patient needs. If the CMS is unable to negotiate the price of a drug, such drug is subject to competitive licensing in order to further its sale under Medicare, notwithstanding existing government-granted exclusivities. Additionally, for one year after a drug is provided under a competitive license, such drug is also subject to specified price limitations; if the drug is not offered at such prices, the drug is subject to additional licensing that furthers its sale under any federal program (e.g., Medicaid).

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Medicare Negotiation and Competitive Licensing Act of 2019

Sponsors

Rep. Lloyd Doggett [D-TX]Sen. Peter Welch [D-VT]Rep. Elijah Cummings [D-MD]Rep. Alma Adams [D-NC]
Rep. Karen Bass [D-CA]Rep. Joyce Beatty [D-OH]Rep. Earl Blumenauer [D-OR]Rep. Suzanne Bonamici [D-OR]
Rep. Matthew Cartwright [D-PA]Rep. Ed Case [D-HI]Rep. Sean Casten [D-IL]Rep. Kathy Castor [D-FL]
Rep. Joaquin Castro [D-TX]Rep. Judy Chu [D-CA]Rep. David Cicilline [D-RI]Rep. Gil Cisneros [D-CA]
Rep. Lacy Clay [D-MO]Rep. Emanuel Cleaver [D-MO]Rep. Steve Cohen [D-TN]Rep. Joe Courtney [D-CT]
Rep. Charlie Crist [D-FL]Rep. Jason Crow [D-CO]Rep. Danny Davis [D-IL]Rep. Peter DeFazio [D-OR]
Rep. Rosa DeLauro [D-CT]Rep. Mark DeSaulnier [D-CA]Rep. Debbie Dingell [D-MI]Rep. Michael Doyle [D-PA]
Rep. Veronica Escobar [D-TX]Rep. Adriano Espaillat [D-NY]Rep. Dwight Evans [D-PA]Rep. Lois Frankel [D-FL]
Rep. Ruben Gallego [D-AZ]Rep. John Garamendi [D-CA]Rep. Jared Golden [D-ME]Rep. Vicente Gonzalez [D-TX]
Rep. Al Green [D-TX]Rep. Raul Grijalva [D-AZ]Rep. Debra Haaland [D-NM]Rep. Josh Harder [D-CA]
Rep. Alcee Hastings [D-FL]Rep. Brian Higgins [D-NY]Rep. Katie Hill [D-CA]Rep. Sheila Jackson-Lee [D-TX]
Rep. Pramila Jayapal [D-WA]Rep. Eddie Johnson [D-TX]Rep. Marcy Kaptur [D-OH]Rep. Ro Khanna [D-CA]
Rep. Andy Kim [D-NJ]Rep. Ann Kirkpatrick [D-AZ]Rep. Raja Krishnamoorthi [D-IL]Rep. James Langevin [D-RI]
Rep. John Larson [D-CT]Rep. Al Lawson [D-FL]Rep. Barbara Lee [D-CA]Rep. Suzanne Lee [D-NV]
Rep. Andy Levin [D-MI]Rep. John Lewis [D-GA]Rep. Daniel Lipinski [D-IL]Rep. David Loebsack [D-IA]
Rep. Zoe Lofgren [D-CA]Rep. Alan Lowenthal [D-CA]Rep. Stephen Lynch [D-MA]Rep. Carolyn Maloney [D-NY]
Rep. Sean Maloney [D-NY]Rep. Betty McCollum [D-MN]Rep. Jerry McNerney [D-CA]Rep. Gwen Moore [D-WI]
Rep. Jerrold Nadler [D-NY]Rep. Grace Napolitano [D-CA]Rep. Joseph Neguse [D-CO]Rep. Eleanor Norton [D-DC]
Rep. Alexandria Ocasio-Cortez [D-NY]Rep. Ilhan Omar [D-MN]Rep. Ed Perlmutter [D-CO]Rep. Collin Peterson [D-MN]
Rep. Dean Phillips [D-MN]Rep. Chellie Pingree [D-ME]Rep. Mark Pocan [D-WI]Rep. Katie Porter [D-CA]
Rep. Ayanna Pressley [D-MA]Rep. Jamie Raskin [D-MD]Rep. Cedric Richmond [D-LA]Rep. Max Rose [D-NY]
Rep. Lucille Roybal-Allard [D-CA]Rep. C.A. Ruppersberger [D-MD]Rep. Bobby Rush [D-IL]Rep. Tim Ryan [D-OH]
Rep. John Sarbanes [D-MD]Rep. Janice Schakowsky [D-IL]Rep. Adam Schiff [D-CA]Rep. Robert Scott [D-VA]
Rep. Jose Serrano [D-NY]Rep. Brad Sherman [D-CA]Rep. Elissa Slotkin [D-MI]Rep. Abigail Spanberger [D-VA]
Rep. Thomas Suozzi [D-NY]Rep. Mark Takano [D-CA]Rep. Bennie Thompson [D-MS]Rep. Dina Titus [D-NV]
Rep. Rashida Tlaib [D-MI]Rep. Norma Torres [D-CA]Rep. Nydia Velazquez [D-NY]Rep. Peter Visclosky [D-IN]
Rep. Debbie Wasserman Schultz [D-FL]Rep. Maxine Waters [D-CA]Rep. Susan Wild [D-PA]Rep. John Yarmuth [D-KY]
Rep. Tom Malinowski [D-NJ]Rep. Jesus Garcia [D-IL]Rep. Joseph Morelle [D-NY]Rep. Darren Soto [D-FL]
Rep. Antonio Delgado [D-NY]Rep. Jared Huffman [D-CA]Rep. Yvette Clarke [D-NY]Rep. Tulsi Gabbard [D-HI]
Rep. Ted Lieu [D-CA]Rep. Frederica Wilson [D-FL]Rep. Mary Gay Scanlon [D-PA]Rep. Debbie Mucarsel-Powell [D-FL]
Rep. David Price [D-NC]Rep. Marcia Fudge [D-OH]Rep. Don Beyer [D-VA]Rep. Elaine Luria [D-VA]
Rep. Andre Carson [D-IN]Rep. Christopher Pappas [D-NH]Rep. Brenda Lawrence [D-MI]Rep. Hakeem Jeffries [D-NY]

History

DateChamberAction
2019-09-25HouseSubcommittee Hearings Held.
2019-02-08HouseReferred to the Subcommittee on Health.
2019-02-07HouseReferred to the Subcommittee on Health.
2019-02-07HouseReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2019-02-07HouseReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2019-02-07HouseIntroduced in House

Same As/Similar To

SB377 (Related) 2019-02-07 - Read twice and referred to the Committee on Finance.

Subjects


US Congress State Sources


Bill Comments

feedback